Inspection Findings:
Based on interview and record review it was determined the facility failed to comprehensively assess 8 of 14 sampled residents (#s 25, 26, 32, 36, 52, 55, 57 and 114) reviewed for medications, pressure ulcers, ADLs, pain and nutrition. This placed residents at risk for unassessed needs. Findings include:
1. Resident 57 was admitted to the facility on 4/2024 with diagnoses including chronic heart failure and diabetes.
The 4/25/24 Admission MDS indicated Resident 57 received an antidepressant medication.
The Psychotropic Drug Use CAA associated with the 4/25/24 MDS indicated "psych meds per physician orders." The CAA did not indicate a description of the problem, causes and contributing factors or how the resident's symptoms manifested or whether the medication was effective.
On 5/20/24 at 8:58 AM Staff 16 (MDS Coordinator) stated she was responsible for completing the MDS assessment and CAAs for all residents. Staff 16 stated she worked remotely and reviewed resident electronic medical records to complete the CAA section.
On 5/20/24 at 1:13 PM Staff 2 (DNS) stated she was unfamiliar with the process of completing the CAAs. Staff 2 stated Staff 16 was responsible for the MDS and CAA assessments, and there was daily communication regarding residents' assessments. Staff 1 (Administrator) and Staff 2 acknowledged the CAA was not comprehensive.
2. Resident 55 was admitted to the facility on 4/2024 with diagnoses including a Stage 3 (full thickness tissue loss) pressure ulcer to the tailbone.
The Pressure Ulcer CAA dated 4/22/24 indicated Resident 55 "needs assist with adls and transfers, has pressure injury to buttocks." The CAA did not include a description of the problem, causes and contributing factors, any alternatives discussed or tried or an overall analysis of the pressure ulcer.
On 5/20/24 at 8:58 AM Staff 16 (MDS Coordinator) stated she was responsible for completing the MDS assessment and CAAs for all residents. Staff 16 stated she worked remotely and reviewed resident electronic medical records to complete the CAA section.
On 5/20/24 at 1:13 PM Staff 2 (DNS) stated she was unfamiliar with the process of completing the CAAs. Staff 2 stated Staff 16 was responsible for the MDS and CAA assessments, and there was daily communication regarding residents' assessments. Staff 1 (Administrator) and Staff 2 acknowledged the CAA was not comprehensive.
3. Resident 36 was admitted to the facility on 9/2022 with diagnoses including arthritis and polyneuropathy (nerve pain).
The 11/17/23 Significant Change MDS and the 2/15/25 Quarterly MDS indicated Resident 36 received scheduled and PRN pain medication.
The Pain CAA associated with the 11/17/23 MDS indicated "no change to plan of care." The CAA did not include a description of, how the resident displayed pain symptoms or whether the medications and any other interventions were effective.
On 5/20/24 at 8:58 AM Staff 16 (MDS Coordinator) stated she was responsible for completing the MDS assessment and CAAs for all residents. Staff 16 stated she worked remotely and reviewed resident electronic medical records to complete the CAA section.
On 5/20/24 at 1:13 PM Staff 2 (DNS) stated she was unfamiliar with the process of completing the CAAs. Staff 2 stated Staff 16 was responsible for the MDS and CAA assessments, and there was daily communication regarding residents' assessments. Staff 1 (Administrator) and Staff 2 acknowledged the CAA was not comprehensive.
4. Resident 114 was admitted to the facility on 2/2024 with diagnoses including end stage renal disease and depression.
The 2/20/24 Admission MDS indicated Resident 57 received an antidepressant medication and was occasionally incontinent of urine and frequently incontinent of bowel.
The CAAs associated with the 2/20/24 MDS revealed the following:
-The Psychotropic Drug Use CAA indicated "takes anti-depressants per physician orders." The CAA did not indicate a description of the problem, causes and contributing factors, how the resident's symptoms manifested or whether the medications were effective.
-The Urinary Incontinence and Indwelling Catheter CAA indicated "has occasional incontinence and requires assistance with toileting." The CAA did not indicate a description of the problem, causes or contributing factors.
On 5/20/24 at 8:58 AM Staff 16 (MDS Coordinator) stated she was responsible for completing the MDS assessment and CAAs for all residents. Staff 16 stated she worked remotely and reviewed resident electronic medical records to complete the CAA section.
On 5/20/24 at 1:13 PM Staff 2 (DNS) stated she was unfamiliar with the process of completing the CAAs. Staff 2 stated Staff 16 was responsible for the MDS and CAA assessments, and there was daily communication regarding residents' assessments. Staff 1 (Administrator) and Staff 2 acknowledged the CAA was not comprehensive.
,
5. Resident 25 admitted to the facility in 6/2022 with diagnoses including falls and chronic pain syndrome.
The 6/20/23 Annual MDS indicated Resident 25 received scheduled and PRN pain medication.
The Pain CAA associated with the 6/20/23 MDS indicated Resident 25 had pain that affected sleep, day-to-day activities and almost constant pain. The CAA did not include a location of the pain, how the resident displayed pain symptoms or whether the medications and other pain interventions were effective.
On 5/20/24 at 8:58 AM Staff 16 (MDS Coordinator) stated she was responsible for completing the MDS assessment and CAAs for all residents. Staff 16 stated she worked remotely and reviewed resident electronic medical records to complete the CAA section. Staff 16 further stated she communicated as needed with the Resident Care Managers and the IDT (Interdisciplinary Team).
On 5/20/24 at 1:13 PM Staff 2 (DNS) stated she was unfamiliar with the process of completing the CAAs. Staff 2 stated Staff 16 was responsible for the MDS and CAA assessments, and there was daily communication regarding residents' assessments.
6. Resident 32 admitted to the facility in 3/2024 with diagnoses including right lower extremity cellulitis and diabetes.
The 3/26/24 Admission MDS indicated Resident 32 received an antidepressant medication.
The Psychotropic Drug Use CAA associated with the 3/26/24 MDS indicated "antidepressant use per physician orders." The CAA did not indicate a description of the problem, causes and the contributing factors, how the resident's symptoms manifested, or whether the medication was effective.
On 5/20/24 at 8:58 AM Staff 16 (MDS Coordinator) stated she was responsible for completing the MDS assessment and CAAs for all residents. Staff 16 stated she worked remotely and reviewed resident electronic medical records to complete the CAA section. Staff 16 further stated she communicated as needed with the Resident Care Managers and the IDT (Interdisciplinary Team).
On 5/20/24 at 1:13 PM Staff 2 (DNS) stated she was unfamiliar with the process of completing the CAAs. Staff 2 stated Staff 16 was responsible for the MDS and CAA assessments, and there was daily communication regarding residents' assessments.
,
7. Resident 26 was admitted to the facility in 1/2024 with diagnoses including glaucoma and depression.
The 1/15/24 Admission MDS indicated Resident 26 had adequate vision and received an antidepressant medication.
The CAAs associated with the 1/15/24 MDS revealed the following:
-The Visual Function CAA indicated "has glaucoma." No further information was provided specific to the resident's current visual functioning, use of visual appliances, or other treatments in place.
-The Psychotropic Drug Use CAA indicated "takes antidepressants for depression." The CAA did not indicate a description of the problem, causes and contributing factors or how the resident's symptoms manifested or whether the medication was effective.
On 5/20/24 at 8:58 AM Staff 16 (MDS Coordinator) stated she was responsible for completing the MDS assessment and CAAs for all residents. Staff 16 stated she worked remotely and reviewed resident electronic medical records to complete the CAA section.
On 5/20/24 at 1:13 PM Staff 2 (DNS) stated she was unfamiliar with the process of completing the CAAs. Staff 2 stated Staff 16 was responsible for the MDS and CAA assessments, and there was daily communication regarding residents' assessments. Staff 1 (Administrator) and Staff 2 acknowledged the CAAs were not comprehensive.
8. Resident 52 was admitted to the facility in 4/2024 with diagnoses including depression.
The 4/10/24 Admission MDS indicated Resident 52 received an antidepressant medication.
The Psychotropic Drug Use CAA associated with the 4/10/24 MDS indicated "received antidepressant per physicians orders." The CAA did not indicate a description of the problem, causes and contributing factors or how the resident's symptoms manifested or whether the medication was effective.
On 5/20/24 at 8:58 AM Staff 16 (MDS Coordinator) stated she was responsible for completing the MDS assessment and CAAs for all residents. Staff 16 stated she worked remotely and reviewed resident electronic medical records to complete the CAA section.
On 5/20/24 at 1:13 PM Staff 2 (DNS) stated she was unfamiliar with the process of completing the CAAs. Staff 2 stated Staff 16 was responsible for the MDS and CAA assessments, and there was daily communication regarding residents' assessments. Staff 1 (Administrator) and Staff 2 acknowledged the CAA was not comprehensive.
Plan of Correction:
The CAAs for Residents 25, 26, 32, 36, 52, 55, 57, and 114 were updated and the residents were assessed for medications, pressure ulcers, ADLs, pain and/or nutrition as indicated on the MDS.
Resident Care Managers (RCMs) or Designee audited CAAs for current residents, addressing any concerns identified.
The DNS or Designee re-educated RCMs and MDS Coordinator on the importance of comprehensive CAAs.
The DNS or Designee will conduct random audits of resident CAAs weekly for 4 weeks and then monthly for 2 months.
The DNS or Designee will report the result of this audit at the facility monthly QAPI meeting for 60 days or until substantial compliance has been achieved as determined by the committee.
The Administrator is responsible for ensuring compliance.